These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12874699)

  • 1. Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy.
    Siomou E; Challa A; Tzoufi M; Papadopoulou ZL; Lapatsanis PD; Siamopoulou A
    Calcif Tissue Int; 2003 Oct; 73(4):319-25. PubMed ID: 12874699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in markers of bone formation and resorption in a bed rest model of weightlessness.
    Lueken SA; Arnaud SB; Taylor AK; Baylink DJ
    J Bone Miner Res; 1993 Dec; 8(12):1433-8. PubMed ID: 8304043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.
    Duzen O; Erkoc R; Begenik H; Soyoral YU; Aldemir MN
    Ren Fail; 2012; 34(3):338-42. PubMed ID: 22260330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of glucocorticoid treatment on serum osteocalcin levels in asthmatic children.
    Jan JS; Wu WF
    J Microbiol Immunol Infect; 2000 Mar; 33(1):25-8. PubMed ID: 10806960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
    Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
    Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of short-term calcium supplementation on biochemical markers of bone metabolism in healthy young adults.
    Ginty F; Flynn A; Cashman KD
    Br J Nutr; 1998 Nov; 80(5):437-43. PubMed ID: 9924265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion.
    Topaloglu AK; Yildizdas D; Yilmaz HL; Mungan NO; Yuksel B; Ozer G
    Bone; 2005 Jul; 37(1):122-7. PubMed ID: 15869925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
    Liesegang A; Reutter R; Sassi ML; Risteli J; Kraenzlin M; Riond JL; Wanner M
    Am J Vet Res; 1999 Aug; 60(8):949-53. PubMed ID: 10451203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.
    Cosman F; Nieves J; Herbert J; Shen V; Lindsay R
    J Bone Miner Res; 1994 Jul; 9(7):1097-105. PubMed ID: 7942157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydroxyproline in morning urine. A reliable parameter for bone turnover in childhood].
    Kruse K; Kracht U
    Monatsschr Kinderheilkd; 1983 Nov; 131(11):797-803. PubMed ID: 6664348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy.
    Kannisto S; Korppi M; Arikoski P; Remes K; Voutilainen R
    Pediatr Res; 2002 Aug; 52(2):258-62. PubMed ID: 12149504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the steroid-sparing response to low-dose methotrexate on bone metabolism in glucocorticoid-dependent asthmatics.
    Girgis SI; Nwokeji A; Shakur BH; Ind PW; Shiner RJ
    Clin Chim Acta; 2004 Mar; 341(1-2):157-63. PubMed ID: 14967172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover for the clinical assessment of bone metabolism.
    Taylor AK; Lueken SA; Libanati C; Baylink DJ
    Rheum Dis Clin North Am; 1994 Aug; 20(3):589-607. PubMed ID: 7984780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis.
    Akesson K; Käkönen SM; Josefsson PO; Karlsson MK; Obrant KJ; Pettersson K
    J Bone Miner Metab; 2005; 23(1):30-5. PubMed ID: 15616891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.